Because discovering new biomarkers is a main challenge in malignant glioma, and given the well-known role of VE-cadherin in stabilizing endothelial cell junctions, the goal of the present study was to characterize the post-translational processing of the protein in human brain tumors. This evidence concerns the gene CDH5 and brain neoplasm.